{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T16:30:40Z","timestamp":1782145840347,"version":"3.54.5"},"reference-count":64,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","pathologyjournal.rcpa.edu.au","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.pathol.2019.11.002","type":"journal-article","created":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T20:06:55Z","timestamp":1577995615000},"page":"167-178","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["A practical guide to laboratory investigations at diagnosis and follow up in Waldenstr\u00f6m macroglobulinaemia: recommendations from the Medical and Scientific Advisory Group, Myeloma Australia, the Pathology Sub-committee of the Lymphoma and Related Diseases Registry and the Australasian Association of Clinical Biochemists Monoclonal Gammopathy Working Group"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5320-4707","authenticated-orcid":false,"given":"M. Gohar","family":"Maqbool","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantine S.","family":"Tam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian M.","family":"Morison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9768-7413","authenticated-orcid":false,"given":"David","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Mollee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0156-4655","authenticated-orcid":false,"given":"Henry","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surender","family":"Juneja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1404-0794","authenticated-orcid":false,"given":"Yasmin","family":"Harvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshmi","family":"Nath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0663-6312","authenticated-orcid":false,"given":"Pravin","family":"Hissaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Miles","family":"Prince","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Wordsworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Opat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipti","family":"Talaulikar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathol.2019.11.002_bib1","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.3109\/10428194.2012.656103","article-title":"Waldenstrom macroglobulinemia: a surveillance, epidemiology, and end results database review from 1988 to 2005","volume":"53","author":"Sekhar","year":"2012","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.pathol.2019.11.002_bib2","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.3324\/haematol.2017.172718","article-title":"Pattern of somatic mutations in patients with Waldenstrom macroglobulinemia or IgM monoclonal gammopathy of undetermined significance","volume":"102","author":"Varettoni","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2019.11.002_bib3","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1001\/jamaoncol.2016.5763","article-title":"Diagnosis and management of Waldenstrom macroglobulinemia: mayo stratification of macroglobulinemia and risk-adapted therapy (mSMART) guidelines 2016","volume":"3","author":"Kapoor","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.pathol.2019.11.002_bib4","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1182\/blood-2014-09-602565","article-title":"The cellular origin and malignant transformation of Waldenstrom macroglobulinemia","volume":"125","author":"Paiva","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.11.002_bib5","series-title":"WHO Classification of Tumours of Haemopoietic and Lymphoid Tissues","year":"2017"},{"key":"10.1016\/j.pathol.2019.11.002_bib6","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.hoc.2014.06.005","article-title":"Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma","volume":"28","author":"Kyle","year":"2014","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.pathol.2019.11.002_bib7","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1182\/blood-2003-03-0801","article-title":"Long-term follow-up of IgM monoclonal gammopathy of undetermined significance","volume":"102","author":"Kyle","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.11.002_bib8","doi-asserted-by":"crossref","first-page":"4928","DOI":"10.1182\/blood-2009-08-237651","article-title":"Evidence of serum immunoglobulin abnormalities up to 9.8 years before diagnosis of chronic lymphocytic leukemia: a prospective study","volume":"114","author":"Tsai","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.11.002_bib9","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1200\/JCO.2000.18.1.214","article-title":"Waldenstrom's macroglobulinemia: clinical features, complications, and management","volume":"18","author":"Dimopoulos","year":"2000","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pathol.2019.11.002_bib10","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/ncpneuro0917","article-title":"Neurological manifestations of Waldenstrom macroglobulinemia","volume":"4","author":"Baehring","year":"2008","journal-title":"Nat Clin Pract Neurol"},{"key":"10.1016\/j.pathol.2019.11.002_bib11","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1751-553X.2008.01100.x","article-title":"ICSH guidelines for the standardization of bone marrow specimens and reports","volume":"30","author":"Lee","year":"2008","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.pathol.2019.11.002_bib12","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1053\/sonc.2003.50082","article-title":"Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia","volume":"30","author":"Owen","year":"2003","journal-title":"Semin Oncol"},{"key":"10.1016\/j.pathol.2019.11.002_bib13","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1093\/annonc\/mdl109","article-title":"Mast cells in Waldenstrom's macroglobulinemia support lymphoplasmacytic cell growth through CD154\/CD40 signaling","volume":"17","author":"Tournilhac","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1016\/j.pathol.2019.11.002_bib14","doi-asserted-by":"crossref","first-page":"580","DOI":"10.5858\/arpa.2012-0034-RS","article-title":"Lymphoplasmacytic lymphoma and Waldenstrom macroglobulinemia","volume":"137","author":"Naderi","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.pathol.2019.11.002_bib15","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1097\/PAS.0b013e3181758806","article-title":"Fluorescence immunophenotypic and interphase cytogenetic characterization of nodal lymphoplasmacytic lymphoma","volume":"32","author":"Sargent","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2019.11.002_bib16","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.beha.2016.08.024","article-title":"Origin of Waldenstrom's macroglobulinaemia","volume":"29","author":"Garcia-Sanz","year":"2016","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.pathol.2019.11.002_bib17","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.clml.2013.02.018","article-title":"Immunoglobulin M concentration in Waldenstrom macroglobulinemia: correlation with bone marrow B cells and plasma cells","volume":"13","author":"de Tute","year":"2013","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.pathol.2019.11.002_bib18","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1136\/jcp.2010.088591","article-title":"Bone-marrow plasma cell burden correlates with IgM paraprotein concentration in Waldenstrom macroglobulinaemia","volume":"64","author":"Pasricha","year":"2011","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.pathol.2019.11.002_bib19","series-title":"Flow Cytometry, Immunohistochemistry, and Molecular Genetics for Hematologic Neoplasms","author":"Sun","year":"2011"},{"key":"10.1016\/j.pathol.2019.11.002_bib20","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1365-2141.2006.06389.x","article-title":"6q deletion in Waldenstrom macroglobulinemia is associated with features of adverse prognosis","volume":"136","author":"Ocio","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2019.11.002_bib21","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3324\/haematol.2012.070458","article-title":"Chromosomal aberrations and their prognostic value in a series of 174 untreated patients with Waldenstrom's macroglobulinemia","volume":"98","author":"Nguyen-Khac","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2019.11.002_bib22","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1056\/NEJMoa1200710","article-title":"MYD88 L265P somatic mutation in Waldenstrom's macroglobulinemia","volume":"367","author":"Treon","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pathol.2019.11.002_bib23","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1182\/blood-2012-09-457101","article-title":"Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstrom's macroglobulinemia and related lymphoid neoplasms","volume":"121","author":"Varettoni","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.11.002_bib24","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/bjh.15049","article-title":"MYD88 wild-type Waldenstrom Macroglobulinaemia: differential diagnosis, risk of histological transformation, and overall survival","volume":"180","author":"Treon","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2019.11.002_bib25","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/ajh.24955","article-title":"MYD88 mutation status does not impact overall survival in Waldenstrom macroglobulinemia","volume":"93","author":"Abeykoon","year":"2018","journal-title":"Am J Hematol"},{"key":"10.1016\/j.pathol.2019.11.002_bib26","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1182\/bloodadvances.2018022962","article-title":"Insights into the genomic landscape of MYD88 wild-type Waldenstrom macroglobulinemia","volume":"2","author":"Hunter","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.pathol.2019.11.002_bib27","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1182\/blood-2012-09-454355","article-title":"MYD88 L265P in Waldenstrom macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction","volume":"121","author":"Xu","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.11.002_bib28","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1002\/ajh.23545","article-title":"Genome wide SNP array identified multiple mechanisms of genetic changes in Waldenstrom macroglobulinemia","volume":"88","author":"Poulain","year":"2013","journal-title":"Am J Hematol"},{"key":"10.1016\/j.pathol.2019.11.002_bib29","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1182\/blood-2013-09-525808","article-title":"The genomic landscape of Waldenstrom macroglobulinemia is characterized by highly recurring MYD88 and WHIM-like CXCR4 mutations, and small somatic deletions associated with B-cell lymphomagenesis","volume":"123","author":"Hunter","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.11.002_bib30","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1158\/1078-0432.CCR-15-0646","article-title":"Genomic landscape of CXCR4 mutations in Waldenstr\u00f6m macroglobulinemia","volume":"22","author":"Poulain","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pathol.2019.11.002_bib31","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMc1506192","article-title":"MYD88 Mutations and response to ibrutinib in Waldenstr\u00f6m's macroglobulinemia","volume":"373","author":"Treon","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pathol.2019.11.002_bib32","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1182\/blood.V128.22.2984.2984","article-title":"Mutated MYD88 zygosity and CXCR4 mutation status are important determinants of ibrutinib response and progression free survival in Waldenstrom's macroglobulinemia","volume":"128","author":"Treon","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.11.002_bib33","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/bjh.16088","article-title":"CXCR4 mutation subtypes impact response and survival outcomes in patients with Waldenstr\u00f6m macroglobulinaemia treated with ibrutinib","volume":"187","author":"Castillo","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2019.11.002_bib34","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/bjh.13078","article-title":"MYD88 L265P mutation contributes to the diagnosis of Bing Neel syndrome","volume":"167","author":"Poulain","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2019.11.002_bib35","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1038\/s41375-018-0197-7","article-title":"Detection of MYD88 and CXCR4 mutations in cell-free DNA of patients with IgM monoclonal gammopathies","volume":"32","author":"Bagratuni","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.pathol.2019.11.002_bib36","doi-asserted-by":"crossref","first-page":"14756","DOI":"10.1038\/ncomms14756","article-title":"Circulating tumour DNA reflects treatment response and clonal evolution in chronic lymphocytic leukaemia","volume":"8","author":"Yeh","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.pathol.2019.11.002_bib37","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1373\/clinchem.2009.124461","article-title":"Quantitation of serum monoclonal proteins: relationship between agarose gel electrophoresis and immunonephelometry","volume":"55","author":"Murray","year":"2009","journal-title":"Clin Chem"},{"key":"10.1016\/j.pathol.2019.11.002_bib38","doi-asserted-by":"crossref","first-page":"5152","DOI":"10.1158\/1078-0432.CCR-15-2899","article-title":"IgMkappa and IgMlambda measurements for the assessment of patients with Waldenstrom's macroglobulinaemia","volume":"22","author":"Boyle","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pathol.2019.11.002_bib39","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/bjh.14743","article-title":"Serum IgM level as predictor of symptomatic hyperviscosity in patients with Waldenstrom macroglobulinaemia","volume":"177","author":"Gustine","year":"2017","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2019.11.002_bib40","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/bjh.12760","article-title":"Guidelines on the diagnosis and management of Waldenstrom macroglobulinaemia","volume":"165","author":"Owen","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2019.11.002_bib41","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1182\/blood-2008-08-174961","article-title":"International prognostic scoring system for Waldenstrom macroglobulinemia","volume":"113","author":"Morel","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.11.002_bib42","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.clml.2013.02.016","article-title":"Patients with Waldenstrom macroglobulinemia commonly present with iron deficiency and those with severely depressed transferrin saturation levels show response to parenteral iron administration","volume":"13","author":"Treon","year":"2013","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.pathol.2019.11.002_bib43","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1182\/blood-2011-11-388256","article-title":"Clinical and prognostic implications of low or high level of von Willebrand factor in patients with Waldenstrom macroglobulinemia","volume":"120","author":"Hivert","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.11.002_bib44","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/bjh.14492","article-title":"Investigation and management of IgM and Waldenstrom-associated peripheral neuropathies: recommendations from the IWWM-8 consensus panel","volume":"176","author":"D'Sa","year":"2017","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2019.11.002_bib45","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/ana.410360313","article-title":"Frequency and clinical correlates of anti-neural IgM antibodies in neuropathy associated with IgM monoclonal gammopathy","volume":"36","author":"Nobile-Orazio","year":"1994","journal-title":"Ann Neurol"},{"key":"10.1016\/j.pathol.2019.11.002_bib46","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/hon.2489","article-title":"The use of droplet digital PCR in liquid biopsies: a highly sensitive technique for MYD88\u00a0p.(L265P) detection in cerebrospinal fluid","volume":"36","author":"Hiemcke-Jiwa","year":"2018","journal-title":"Hematol Oncol"},{"issue":"2","key":"10.1016\/j.pathol.2019.11.002_bib47","first-page":"1","article-title":"Amyloidosis associated with Waldenstr\u00f6m disease or IgM MGUS","volume":"14","author":"Giampaolo Merlini","year":"2013","journal-title":"IWMF Torch"},{"key":"10.1016\/j.pathol.2019.11.002_bib48","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1200\/JCO.2015.63.3123","article-title":"European collaborative study defining clinical profile outcomes and novel prognostic criteria in monoclonal immunoglobulin M-related light chain amyloidosis","volume":"34","author":"Sachchithanantham","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pathol.2019.11.002_bib49","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1182\/blood-2014-11-609883","article-title":"A\u00a0practical approach to the diagnosis of systemic amyloidoses","volume":"125","author":"Fernandez de Larrea","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.11.002_bib50","series-title":"Clinical practice guideline: systemic AL amyloidosis","author":"Gibbs","year":"2019"},{"key":"10.1016\/j.pathol.2019.11.002_bib51","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1182\/asheducation.V2012.1.586.3798562","article-title":"Are you sure this is Waldenstrom macroglobulinemia?","volume":"2012","author":"Ghobrial","year":"2012","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1016\/j.pathol.2019.11.002_bib52","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/ajh.10356","article-title":"Fluorescence in situ hybridization: method of choice for a definitive diagnosis of mantle cell lymphoma","volume":"74","author":"Sun","year":"2003","journal-title":"Am J Hematol"},{"key":"10.1016\/j.pathol.2019.11.002_bib53","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1046\/j.1365-2141.2001.03144.x","article-title":"Waldenstr\u00f6m macroglobulinaemia: presenting features and outcome in a series with 217 cases","volume":"115","author":"Garc\u00eda-Sanz","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2019.11.002_bib54","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1053\/sonc.2003.50038","article-title":"Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia","volume":"30","author":"Kyle","year":"2003","journal-title":"Semin Oncol"},{"key":"10.1016\/j.pathol.2019.11.002_bib55","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/bjh.12102","article-title":"Response assessment in Waldenstrom macroglobulinaemia: update from the VIth international Workshop","volume":"160","author":"Owen","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2019.11.002_bib56","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3324\/haematol.2016.147728","article-title":"Guideline for the diagnosis, treatment and response criteria for Bing-Neel syndrome","volume":"102","author":"Minnema","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2019.11.002_bib57","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/annonc\/mdh403","article-title":"Paradoxical increases in serum IgM and viscosity levels following rituximab in Waldenstrom's macroglobulinemia","volume":"15","author":"Treon","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1016\/j.pathol.2019.11.002_bib58","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1002\/cncr.20658","article-title":"Initial immunoglobulin M 'flare' after rituximab therapy in patients diagnosed with Waldenstrom macroglobulinemia: an eastern cooperative oncology group study","volume":"101","author":"Ghobrial","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.pathol.2019.11.002_bib59","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/ajh.25023","article-title":"Ibrutinib discontinuation in Waldenstrom macroglobulinemia: etiologies, outcomes, and IgM rebound","volume":"93","author":"Gustine","year":"2018","journal-title":"Am J Hematol"},{"key":"10.1016\/j.pathol.2019.11.002_bib60","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/bjh.14881","article-title":"Transformed Waldenstrom macroglobulinaemia: clinical presentation and outcome. A multi-institutional retrospective study of 77 cases from the French Innovative Leukemia Organization (FILO)","volume":"179","author":"Durot","year":"2017","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2019.11.002_bib61","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1182\/blood.V128.22.2982.2982","article-title":"Retrospective analysis of 56 cases of transformed Waldenstr\u00f6m macroglobulinemia. A study on behalf of the French Innovative Leukemia Organization (FILO)","volume":"128","author":"Durot","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.11.002_bib62","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2017.72","article-title":"From Waldenstrom's macroglobulinemia to aggressive diffuse large B-cell lymphoma: a whole-exome analysis of abnormalities leading to transformation","volume":"7","author":"Jimenez","year":"2017","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.pathol.2019.11.002_bib63","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/bjh.15610","article-title":"Genetic analysis of diffuse large b-cell lymphoma occurring in cases with antecedent Waldenstrom macroglobulinaemia reveals different patterns of clonal evolution","volume":"185","author":"Talaulikar","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2019.11.002_bib64","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/imj.13311","article-title":"Treatment of patients with Waldenstr\u00f6m macroglobulinaemia: clinical practice guidelines from the Myeloma Foundation of Australia Medical and Scientific Advisory Group","volume":"47","author":"Talaulikar","year":"2017","journal-title":"Intern Med J"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302519304386?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302519304386?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T21:03:16Z","timestamp":1579899796000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302519304386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":64,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S0031302519304386"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2019.11.002","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A practical guide to laboratory investigations at diagnosis and follow up in Waldenstr\u00f6m macroglobulinaemia: recommendations from the Medical and Scientific Advisory Group, Myeloma Australia, the Pathology Sub-committee of the Lymphoma and Related Diseases Registry and the Australasian Association of Clinical Biochemists Monoclonal Gammopathy Working Group","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2019.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2019 Published by Elsevier B.V. on behalf of Royal College of Pathologists of Australasia. All rights reserved.","name":"copyright","label":"Copyright"}]}}